Navigation Links
Bunge Reports Fourth Quarter Net Income of $245 Million
Date:2/7/2008

WHITE PLAINS, N.Y., Feb. 7 /PRNewswire-FirstCall/ -- Bunge Limited (NYSE: BG)

-- Total segment operating profit increased 77% when compared to the same

quarter last year

-- Agribusiness benefited from improved global market conditions, posting

14% volume growth in the quarter

-- Fertilizer continued to benefit from improved farm economics and high

international prices

Financial Highlights

(In millions, except per share data and percentages)

Quarter Ended Year Ended

12/31/07 12/31/06 % Change 12/31/07 12/31/06 % Change

Volumes (metric tons) 34.1 30.8 11 % 137.0 120.1 14 %

Net Sales $14,018 $7,683 82 % $44,804 $26,274 71 %

Total segment

operating

profit (1,2) $340 $192 77 % $1,162 $443 162 %

Net income (2) $245 $264 (7)% $778 $521 49 %

Earnings per common

share - diluted (3) $1.82 $2.12 (14)% $5.95 $4.28 39 %

(1) Total segment operating profit is the consolidated segment operating

profit of Bunge's segments. Total segment operating profit is a non-

GAAP measure and is not intended to replace income from operations

before income tax, the most directly comparable GAAP measure. The

information required by Regulation G under the Securities Exchange Act

of 1934, including a reconciliation to income from operations before

income tax, is included in the tables attached to this press release.

(2) Bunge's results included certain gains and charges that may be of

COME

(In millions, except per share data and percentages)

(Unaudited)

Quarter Ended Year Ended

December 31, Percent December 31, Percent

2007 2006 Change 2007 2006 Change

Net sales $14,018 $7,683 82% $44,804 $26,274 71%

Cost of goods

sold (13,242) (7,169) 85% (42,289) (24,703) 71%

Gross profit 776 514 51% 2,515 1,571 60%

Selling, general

and administrative

expenses (434) (278) 56% (1,359) (978) 39%

Interest income 54 32 69% 166 119 39%

Interest expense (73) (68) (7)% (217) (195) 11%

Interest expense on

readily marketable

inventories (29) (18) 61% (136) (85) 60%

Foreign exchange

gain (loss) 39 24 217 59

Other income

(expense) - net 17 24 (29)% 15 31 (52)%

Income from

operations before

income tax 350 230 52% 1,201 522 130%

Income tax

(expense)

benefit (89) 69 (310) 36

Income from

operations after

income tax 261 299 (13)% 891 558 60%

Minority interest (42) (22) 91% (146) (60) 143%

Equity in earnings

of affiliates 26 (13) 300% 33 23 43%

Net income 245 264 (7)% 778 521 49%

Convertible

preference

share dividends (15) (4) (40) (4)

Net income

available

to common

shareholders $230 $260 (12)% $738 $517 43%

Earnings per common

share - diluted

(Note 1): $1.82 $2.12 (14)% $5.95 $4.28 39%

Weighted-average

common shares

outstanding

-diluted

(Note 1) 134,501,104 124,409,362 130,753,807 120,849,357

Note 1: The dilutive effect of the of 11,661,359 and 8,536,729 weighted

average common shares, which would be issuable upon conversion of

Bunge's convertible preference shares, is included in the

earnings per common share - diluted calculation for the quarter

and year ended December 31, 2007, respectively, because the

effect of the conversion would have been dilutive.

CONSOLIDATED SEGMENT INFORMATION

(In millions, except volumes and percentages)

(Unaudited) (Note 1 and 2)

Set forth below is a summary of certain items in our consolidated

statements of income and volumes by reportable segment.

Quarter Ended Year Ended

December 31, Percent December 31, Percent

2007 2006 Change 2007 2006 Change

Volumes (in thousands

of metric tons):

Agribusiness 28,104 24,645 14% 114,365 99,801 15%

Fertilizer 3,548 3,921 (10)% 13,077 11,578 13%

Edible oil products 1,461 1,266 15% 5,530 4,777 16%

Milling products 973 933 4% 3,983 3,895 2%

Total 34,086 30,765 11% 136,955 120,051 14%

Net sales:

Agribusiness $10,481 $5,471 92% $33,877 $18,909 79%

Fertilizer 1,280 918 39% 3,944 2,602 52%

Edible oil products 1,840 1,043 76% 5,622 3,798 48%

Milling products 417 251 66% 1,361 965 41%

Total $14,018 $7,683 82% $44,804 $26,274 71%

Gross profit:

Agribusiness $496 $280 77% $1,407 $818 72%

Fertilizer (Note 3) 157 125 26% 639 326 96%

Edible oil products 102 69 48% 334 289 16%

Milling products 21 40 (48)% 135 138 (2)%

Total $776 $514 51% $2,515 $1,571 60%

Selling, general and

administrative

expenses:

Agribusiness $(210) $(156) 35% $(661) $(516) 28%

Fertilizer (85) (49) 73% (284) (190) 49%

Edible oil products (105) (55) 91% (316) (207) 53%

Milling products (34) (18) 89% (98) (65) 51%

Total $(434) $(278) 56% $(1,359) $(978) 39%

Foreign exchange gain

(loss):

Agribusiness $48 $8 $136 $(12)

Fertilizer 17 9 114 47

Edible oil products 3 3 6 5

Milling products (1) - (4) -

Total $67 $20 $252 $40

Interest income:

Agribusiness $15 $7 114% $38 $27 41%

Fertilizer 16 14 14% 64 58 10%

Edible oil products 2 - 100% 4 2 100%

Milling products - 1 (100)% 1 3 (67)%

Total $33 $22 50% $107 $90 (19)%

Interest expense:

Agribusiness $(85) $(64) 33% $(296) $(203) 46%

Fertilizer (2) (11) (82)% (16) (39) (59)%

Edible oil products (15) (9) 67% (38) (31) 23%

Milling products - (2) (100)% (3) (7) (57)%

Total $(102) $(86) 19% $(353) $(280) 26%

Segment operating profit

(loss):

Agribusiness $264 $75 252% $624 $114 447%

Fertilizer 103 88 17% 517 202 156%

Edible oil products (13) 8 (263)% (10) 58 (117)%

Milling products (14) 21 (167)% 31 69 (55)%

Total (Note 4) $340 $192 77% $1,162 $443 162%

Income from operations

before income tax :

Segment operating profit $340 $192 77% $1,162 $443 162%

Unallocated income

- net (Note 5) 10 38 (74)% 39 79 (51)%

Income from operations

before income tax $350 $230 52% $1,201 $522 130%

Depreciation, depletion

and amortization:

Agribusiness $49 $35 40% 157 $126 25%

Fertilizer 44 33 33% 151 130 16%

Edible oil products 17 13 31% 61 53 15%

Milling products 4 4 -% 16 15 7%

Total $114 $85 34% $385 $324 19%

Note 1: In the first quarter of 2007, Bunge reclassified certain product

lines from the edible oil products segment to the agribusiness

segment. As a result, amounts for the quarter and year ended

December 31, 2006 have been reclassified to conform to the

current period presentation.

Note 2: Impairment and restructuring pretax charges in the quarter ended

December 31, 2007 consisted of $25 million in the agribusiness

segment, $29 million in the edible oil products segment, and $13

million in the milling products segment. Impairment and

restructuring pretax charges in the year ended December 31, 2007

consisted of $30 million in the agribusiness segment, $35 million

in the edible oil products segment and $13 million in the milling

products segment. The impairment and restructuring charges for

the quarter and year ended December 31, 2007 were recorded in

cost of goods sold, other than $11 million of the edible oil

products segment total, which was recorded in selling general and

administrative expenses. Impairment and restructuring charges in

the year ended December 31, 2006 consisted of $20 million in the

agribusiness segment and $2 million in the edible oil products

segment, which were recorded in cost of goods sold, and $2

million in the fertilizer segment, which was recorded in selling

general and administrative expenses.

Note 3: Value-added-tax provision of $50 million in the quarter and year

ended December 31, 2007 in the fertilizer segment resulted from a

recent change in tax laws in several Brazilian states that will

take effect in 2008, which will make the recoverability of these

taxes uncertain.

Note 4: Total segment operating profit is the consolidated segment

operating profit of all of Bunge's operating segments. Total

segment operating profit is a non-GAAP measure and is not

intended to replace income from operations before income tax, the

most directly comparable GAAP measure. The information required

by Regulation G under the Securities Exchange Act of 1934,

including the reconciliation to income from operations before

income tax, is included under the caption "Reconciliation of

Non-GAAP Measures".

Note 5: Includes interest income, interest expense and foreign exchange

gains and losses and other income and expenses not directly

attributable to Bunge's operating segments.

CONDENSED CONSOLIDATED BALANCE SHEETS

(In millions)

(Unaudited)

December 31, December 31,

2007 2006

ASSETS

Current assets:

Cash and cash equivalents $981 $365

Trade accounts receivable 2,541 1,879

Inventories 5,924 3,684

Deferred income taxes 211 149

Other current assets 4,886 2,316

Total current assets 14,543 8,393

Property, plant and equipment, net 4,216 3,446

Goodwill 377 236

Other intangible assets, net 116 99

Investments in affiliates 706 649

Deferred income taxes 903 714

Other non-current assets 1,155 810

Total assets $22,016 $14,347

LIABILITIES AND SHAREHOLDERS' EQUITY

Current liabilities:

Short-term debt $590 $454

Current portion of long-term debt 522 156

Trade accounts payable 4,061 2,328

Deferred income taxes 173 54

Other current liabilities 3,513 1,523

Total current liabilities 8,859 4,515

Long-term debt 3,435 2,874

Deferred income taxes 149 180

Other non-current liabilities 876 700

Minority interest in subsidiaries 752 410

Shareholders' equity 7,945 5,668

Total liabilities and shareholders' equity $22,016 $14,347

CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS

(In millions)

(Unaudited)

Year Ended

December 31,

2007 2006

OPERATING ACTIVITIES

Net income $778 $521

Adjustments to reconcile net income to cash

used for operating activities:

Foreign exchange gain on debt (285) (175)

Impairment of assets 70 20

Bad debt expense 48 41

Depreciation, depletion and amortization 385 324

Stock-based compensation expense 48 19

Deferred income taxes (62) (191)

Gain on sale of assets (22) (36)

(Increase) decrease in the allowance for

recoverable taxes (47) 5

Minority interest 146 60

Equity in earnings of affiliates (33) (23)

Changes in operating assets and liabilities,

excluding the effects of acquisitions:

Trade accounts receivable (319) (69)

Inventories (1,743) (729)

Prepaid commodity purchase contracts (184) (88)

Secured advances to suppliers 207 256

Trade accounts payable 1,231 365

Unrealized net gain on derivative contracts (530) (184)

Margin deposits (175) (85)

Other - net 99 (320)

Cash used for operating activities (388) (289)

INVESTING ACTIVITIES

Payments made for capital expenditures (667) (503)

Investments in affiliates (39) (91)

Acquisitions of businesses (net of cash acquired)

and intangible assets (223) (74)

Proceeds from disposal of property, plant

and equipment 55 49

Related party loans (22) (21)

Return of capital from affiliate - 18

Proceeds from sale of investments 23 11

Cash used for investing activities (873) (611)

FINANCING ACTIVITIES

Net change in short-term debt 95 11

Proceeds from long-term debt 2,086 488

Repayments of long-term debt (1,203) (200)

Proceeds from sale of preference shares 845 677

Proceeds from sale of common shares 32 16

Dividends paid to preference shareholders (34) -

Dividends paid to common shareholders (80) (74)

Dividends paid to minority interest (18) (27)

Other 95 -

Cash provided by financing activities 1,818 891

Effect of exchange rate changes on cash

and cash equivalents 59 20

Net increase in cash and cash equivalents 616 11

Cash and cash equivalents, beginning of period 365 354

Cash and cash equivalents, end of period $981 $365

Reconciliation of Non-GAAP Measures

This earnings release contains total segment operating profit, net financial debt and net financial debt less readily marketable inventories, which are "non-GAAP financial measures" as this term is defined in Regulation G of the Securities Exchange Act of 1934. In accordance with Regulation G, Bunge has reconciled these non-GAAP financial measures to the most directly comparable U.S. GAAP measures.

Total Segment Operating Profit

Total segment operating profit, which is the consolidated segment operating profit of all of Bunge's operating segments, is Bunge's consolidated income from operations before income tax that includes interest income of each segment and an allocated portion of the foreign exchange gains and losses and of interest expense relating to debt financing operating working capital, including readily marketable inventories.

Total segment operating profit is a non-GAAP financial measure and is not intended to replace income from operations before income tax, the most directly comparable GAAP financial measure. Total segment operating profit is a key performance measurement used by Bunge's management to evaluate whether operating activities cover the financing costs of its business. Bunge believes total segment operating profit is a more complete measure of its operating profitability, since it allocates foreign exchange gains and losses and the cost of debt financing working capital to the appropriate operating segments. Additionally, Bunge believes total segment operating profit assists investors by allowing them to evaluate changes in the operating results of its portfolio of businesses before non-operating factors that affect net income. Total segment operating profit is not a measure of consolidated operating results under U.S. GAAP and should not be considered as an alternative to income from operations before income tax or any other measure of consolidated operating results under U.S. GAAP.

Below is a reconciliation of income from operations before income tax to total segment operating profit:

Quarter Ended Year Ended

December 31, December 31,

(In millions) 2007 2006 2007 2006

Income from operations

before income tax $350 $230 $1,201 $522

Unallocated income - net(1) (10) (38) (39) (79)

Total segment operating profit $340 $192 $1,162 $443

(1) Includes interest income, interest expense and foreign exchange gains

and losses and other income and expenses not directly attributable to

Bunge's operating segments.

Net Financial Debt

Net financial debt is the sum of short-term debt, current maturities of long-term debt and long-term debt, less cash and cash equivalents and marketable securities. Net financial debt is presented because management believes it represents a meaningful measure of Bunge's leverage capacity and solvency. Net financial debt is not a measure of solvency under U.S. GAAP and should not be considered as an alternative to total debt as a measure of solvency.

Net financial debt less readily marketable inventories (RMI), or net financial debt less RMI, is the sum of short-term debt, current minterest to investors. See the Additional Financial Information

section included in the tables attached to this press release for more

information.

(3) See Note 1 to the consolidated statements of income attached to this

press release for information on the calculation of diluted earnings

per share.

Overview

Alberto Weisser, Bunge's Chairman and Chief Executive Officer stated, "2007 was an outstanding year. Bunge leveraged its integrated, global

operations, leading positions in key markets and good teamwork to produce record results."

"In 2007, the agribusiness and fertilizer markets were characterized by improved structural conditions. Demand for Bunge's end products grew and farm economics in Brazil strengthened. Our risk management strategies performed well in a dynamic market, and we were well-positioned to serve customers during a period marked by significant supply dislocations.

"The conditions that made 2007 compelling should continue in 2008. The USDA forecasts higher global protein meal and vegetable oil demand, as well as strong demand for and trade in other agricultural commodities. Crop prices should remain high, promoting input purchases by farmers. Not all market forces are working in Bunge's favor, however. For example, the strong real will increase local costs in our Brazilian businesses, and higher input costs could pressure margins in fertilizer and edible oils during the year.

"We plan to build on our success by continuing to follow our strategy of investing for growth and efficiency in our core businesses and in complementary value chains. In 2007, we expanded our oilseed processing footprint and launched a regional consumer packaged oil brand in China. We also enhanced processing assets in the Americas and Europe, purchased our first sugarcane mill and established a joint venture with OCP, the Moroccan fertilizer manufacturer, which will provide our business aturities of long-term debt and long-term debt, less cash and cash equivalents, marketable securities and readily marketable inventories. Net financial debt less RMI is presented because management believes it represents a more complete picture of Bunge's leverage capacity and solvency since it adjusts for readily marketable inventories. Readily marketable inventories are agricultural inventories that are readily convertible to cash because of their commodity characteristics, widely available markets and international pricing mechanisms. Net financial debt less RMI is not a measure of leverage capacity and solvency under U.S. GAAP and should not be considered as an alternative to total debt as a measure of solvency.

Below is a reconciliation of total long-term and short-term debt to net financial debt and to net financial debt less readily marketable inventories:

December 31, December 31,

(In millions) 2007 2006

Short-term debt $590 $454

Long-term debt, including current portion 3,957 3,030

Total debt 4,547 3,484

Less:

Cash and cash equivalents 981 365

Marketable securities 5 3

Net financial debt 3,561 3,116

Less: Readily marketable inventories 3,358 2,325

Net financial debt less readily

marketable inventories $203 $791

with a valuable supply of fertilizer raw materials and products. Construction on the venture's production facilities is well underway, and we expect initial phosphoric acid capacity to come online later this year. We are pleased with how our asset network is growing and becoming more balanced across geography and products."

Fourth Quarter Results

Agribusiness Operating Profit

Results increased in most regions and areas of the business. Improved performance in South America and North America were driven by higher oilseed processing and grain origination margins and volumes. Higher distribution results were due to strong global demand and improved margins. Risk management strategies performed well during a volatile quarter.

Fourth quarter results included $25 million of impairment and restructuring charges relating to the closure of oilseed processing facilities in Europe and the U.S. The closure of the European processing plant is a continuation of our strategy to improve the efficiency of our asset footprint in Eastern Europe. The U.S. processing facility was older and high cost. The attached grain elevator will continue to operate.

Fertilizer Operating Profit

The strong performance in fertilizer was due to higher margins, which benefited from higher international fertilizer prices. Selling prices in South America are based on international prices and include the cost of transportation and other import costs. As expected, demand for fertilizer products slowed in the fourth quarter after above trend-line volume growth in the first half of the year, when farmers accelerated purchases because of favorable agricultural commodity prices and concerns about increasing crop input costs.

Fourth quarter results included a $50 million increase in our value-added- tax provision, resulting from a change in tax laws in several Brazilian states that will take effect in 2008 and will make the recoverability of these taxes uncertain.

Edible Oil Products Operating Profit

Improved margins were offset by higher operating expenses, which included investments to grow the business in Asia and Europe.

Fourth quarter results included $29 million of impairment and restructuring charges. These charges primarily relate to the closure of edible oil facilities in Eastern Europe, as well as impairments to goodwill and other intangible assets in India.

Milling Products Operating Profit

Higher raw material and operating costs in wheat milling more than offset improved results in corn milling.

Fourth quarter results included a $13 million impairment charge related to the closure of a wheat milling facility in Brazil. This facility is being replaced by a newer, more efficient facility that will come on-line in 2008.

Financial Costs

Interest expense increased due to higher average borrowings, mostly resulting from the higher prices of agricultural commodity inventories which drove higher average working capital levels.

Foreign exchange gains, incurred primarily on the net U.S. dollar- denominated monetary liability positions of Bunge's Brazilian subsidiaries, were $39 million in the fourth quarter of 2007. These gains largely offset foreign exchange losses on inventories included in gross profit.

Income Taxes

The effective tax rate for the year ended December 31, 2007 was 26%. For the year ended December 31, 2006, Bunge had a tax benefit of $36 million. The increase in the effective tax rate, excluding the one time items which resulted in the tax benefit in 2006, was primarily due to increases in operating earnings in higher tax jurisdictions.

Minority Interest

Minority interest increased when compared to the same quarter in 2006 due to higher earnings at Fosfertil.

Cash Flow

Cash provided by operations in the fourth quarter of 2007 was $254 million compared to cash provided by operations in the fourth quarter of 2006 of $259 million. For the year ended December 31, 2007, cash used by operations increased to $388 million from $289 million in the same period last year, driven by significant increases in commodity prices.

Outlook

Jacqualyn Fouse, Chief Financial Officer, stated, "Looking forward, we expect the improved market fundamentals that we experienced in 2007 to continue into 2008, though as previously mentioned, we do see some headwinds. In consideration of this outlook, our 2008 full-year net income guidance is $830 million to $870 million, or $6.01 to $6.30 per share. This fully diluted per share guidance is based on an estimated weighted average of 138 million shares outstanding, which includes assumed dilution relating to our convertible preference shares."

"Additionally, our 2008 guidance includes the following:

-- Depreciation, Depletion and Amortization: $450 million to $470 million

-- Capital Expenditures (net of asset dispositions): $1 billion to $1.1

billion, of which approximately 30% will be invested in sustaining,

maintenance, safety and environmental projects.

-- Tax Rate: 24% to 28%."

Conference Call and Webcast Details

Bunge Limited's management will host a conference call at 10:00 a.m. EST on Thursday, February 7, 2008, to discuss the company's results.

Additionally, a slide presentation to accompany the discussion of the fourth quarter financial results can be found in the 'Investor Information' section of our Web site, http://www.Bunge.com, under 'Investor Presentations'.

To listen to the conference call, please dial (877) 718-5111. If you are located outside of the United States or Canada, dial (719) 325-4762. Please dial in five to 10 minutes before the scheduled start time. When prompted, enter confirmation code 7165114. The conference call will also be available live on the company's Web site at http://www.Bunge.com.

To access the webcast, click the "News and Information" link on the Bunge homepage then select "Webcasts and Upcoming Events". Click the link for the "Q4 2007 Bunge Limited Conference Call," and follow the prompts to join the call. Please go to the Web site at least 15 minutes prior to the call to register and to download and install any necessary audio software.

For those who cannot listen to the live broadcast, a replay of the call will be available beginning at 1:00 p.m. EST on February 7, 2008 and continuing through 1:00 p.m. EST on March 8, 2008. To listen to the replay, please dial (888) 203-1112, or, if located outside of the United States or Canada, dial (719) 457-0820. When prompted, enter confirmation code 7165114. A rebroadcast of the conference call will also be available on the company's Web site. To locate the rebroadcast on the Web site, click the "News and Information" link on the Bunge homepage then select "Audio Archives" from the left-hand menu. Select the link for the "Q4 2007 Bunge Limited Conference Call." Follow the prompts to access the replay.

About Bunge Limited

Bunge Limited (http://www.Bunge.com, NYSE: BG) is a leading global agribusiness and food company founded in 1818 and headquartered in White Plains, New York. Bunge's over 22,000 employees in over 30 countries enhance lives by improving the global agribusiness and food production chain. The company supplies fertilizer to farmers in South America, originates, transports and processes oilseeds, grains and other agricultural commodities worldwide, produces food products for commercial customers and consumers and supplies raw materials and services to the biofuels industry.

Cautionary Statement Concerning Forward-Looking Statements

This press release contains both historical and forward-looking statements. All statements, other than statements of historical fact are, or may be deemed to be, forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements are not based on historical facts, but rather reflect our current expectations and projections about our future results, performance, prospects and opportunities. We have tried to identify these forward-looking statements by using words including "may," "will," "expect," "anticipate," "believe," "intend," "estimate," "continue" and similar expressions. These forward- looking statements are subject to a number of risks, uncertainties and other factors that could cause our actual results, performance, prospects or opportunities, as well as those of the markets we serve or intend to serve, to differ materially from those expressed in, or implied by, these forward- looking statements. The following important factors, among others, could affect our business and financial performance: our ability to complete, integrate and benefit from acquisitions, divestitures, joint ventures and strategic alliances; estimated demand for the commodities and other products that we sell and use in our business; industry conditions, including the cyclicality of the agribusiness industry and unpredictability of the weather; agricultural, economic and political conditions in the primary markets where we operate; and other economic, business, competitive and/or regulatory factors affecting our business generally. The forward-looking statements included in this release are made only as of the date of this release, and except as otherwise required by federal securities law, we do not have any obligation to publicly update or revise any forward-looking statements to reflect subsequent events or circumstances.

Additional Financial Information

The following table provides a summary of certain gains and charges that may be of interest to investors. The table includes a description of these items and their effect on total segment operating profit, income from operations before income tax, net income and earnings per share for the quarter and year ended December 31, 2007 and 2006.

Income (Loss)

(In millions, Total Segment From Operations Earnings

except per Operating Before Per Share

share data) Profit (Loss) Income Tax Net Income Diluted

Quarter Ended

December 31: 2007 2006 2007 2006 2007 2006 2007 2006

Impairment and

restructuring

charges (1) $(67) $- $(67) $- $(51) $- $(0.38) $-

Value-added tax

provision (2) (50) - (50) - (22) - (0.16) -

Gain on sale of

investments (3) 22 - 22 - 15 - 0.11 -

Reversal of social

contribution/

transactional

tax provision - 6 6 2 - 0.02

Total $(95) $6 $(95) $6 $(58) $2 $0.43 $0.02

Income

(In millions, Total Segment From Operations Earnings

except per Operating Before Per Share

share data) Profit Income Tax Net Income Diluted

Year Ended

December 31: 2007 2006 2007 2006 2007 2006 2007 2006

Impairment and

restructuring

charges (1) $(78) $(24) $(78) $(24) $(59) $(16) $(0.45) $(0.13)

Value-added tax

provision (2) (50) - (50) - (22) - (0.17) -

Gain on sale of

investments (3) 22 - 22 - 15 - 0.11 -

Reversal of social

contribution/

transactional

tax provision - 18 - 18 - 8 - 0.07

Litigation

settlement - 6 - 6 - 4 - 0.03

Total $(106) $- $(106) $- $(66) $(4) $(0.51) $(0.03)

(1) Impairment and restructuring pretax charges in the quarter ended

December 31, 2007 consisted of $25 million in the agribusiness

segment, $29 million in the edible oil products segment, and $13

million in the milling products segment. Impairment and restructuring

pretax charges in the year ended December 31, 2007 consisted of $30

million in the agribusiness segment, $35 million in the edible oil

products segment and $13 million in the milling products segment. The

impairment and restructuring charges for the quarter and year ended

December 31, 2007 were recorded in cost of goods sold, other than $11

million of the edible oil products segment total, which was recorded

in selling general and administrative expenses. Impairment and

restructuring charges in the year ended December 31, 2006 consisted

of $20 million in the agribusiness segment and $2 million in the

edible oil products segment, which were recorded in cost of goods

sold, and $2 million in the fertilizer segment, which was recorded in

selling general and administrative expenses.

(2) Value-added-tax provision of $50 million in the quarter and year ended

December 31, 2007 in the fertilizer segment resulted from a recent

change in tax laws in several Brazilian states that will take effect

in 2008, which will make the recoverability of these taxes uncertain.

(3) Gain on sale of investments of $22 million recorded in other income

(expense)-net in the quarter and year ended December 31, 2007 resulted

from a sale of investment securities.

CONSOLIDATED STATEMENTS OF IN
'/>"/>

SOURCE Bunge Limited
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. Digirad Corporation Reports Financial Results for 2007 Fourth Quarter and Twelve Months
2. ThermoGenesis Corp. Reports 48 Percent Growth in Second Quarter Revenues Year Over Year
3. Senesco Technologies Reports on Results of Preclinical Multiple Myeloma Studies
4. Recent Research Reports and Near-Term Corporate Events
5. Tutogen Medical, Inc. Reports First Quarter Fiscal 2008 Financial Results
6. Thermo Fisher Scientific Reports Record 2007 Fourth Quarter Revenues and Operating Performance; Provides Guidance for 2008
7. Thoratec Reports 10 Percent Increase in Fiscal 2007 Revenues; Fourth Quarter Revenues Largest in Company History
8. Rochester Medical Reports 31% Increase in Branded Sales Resulting in 9% Overall Sales Growth for the First Quarter
9. Wyeth Reports Earnings Results for the 2007 Fourth Quarter and Full Year
10. CuraGen Reports Fourth Quarter and Year End 2007 Financial Results
11. Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/9/2016)... ... February 09, 2016 , ... Clinovo ... free and validated Electronic Data Capture (EDC) system ClinCaptureand its new Contract Research ... West Coast 2016 Conference in San Mateo, California on February 10th and 11th. ...
(Date:2/9/2016)... ... February 09, 2016 , ... PharmApprove ... Policy for the National Organization for Rare Disorders (NORD). Dorman will lead PharmApprove ... voices are heard throughout the drug regulatory review process. , “Adding Diane Dorman ...
(Date:2/9/2016)... , February 9, 2016 Three-Year ... Enables Children to Take Part in Life-Changing Camp ... new initiative designed to positively affect the lives of children born ... care. --> SHPG ) is announcing a new initiative ... diseases, as well as the future of rare disease care. ...
(Date:2/8/2016)... 2016 Should antibiotic bone cement products be ... prevent infection after standard total hip or knee replacement ... Institute have been fielding a lot lately. ... Line?" --> "Antibiotic Bone Cement: ... --> While there isn,t a simple answer, ...
Breaking Biology Technology:
(Date:1/22/2016)... Jan. 22, 2016 ... of the "Global Biometrics Market in ... offering. --> http://www.researchandmarkets.com/research/p74whf/global_biometrics ) ... "Global Biometrics Market in Retail Sector 2016-2020" ... --> Research and Markets ( http://www.researchandmarkets.com/research/p74whf/global_biometrics ...
(Date:1/20/2016)... LONDON , Jan. 20, 2016 A ... positioned to directly benefit from the explosion in genomics ... from Howe Sound Research. A range of dynamic trends ... ...... - personalized medicine - pharmacogenomics - pathogen ... economies with large markets - greater understanding of the ...
(Date:1/20/2016)... JOSE, Calif. , Jan. 20, 2016 /PRNewswire/ ... developer of human interface solutions, today announced sampling ... controller solution for wearables and small screen applications ... such as printers. Supporting round and rectangular shapes, ... S1423 offers excellent performance with moisture on screen, ...
Breaking Biology News(10 mins):